CryoLife, Inc. (NYSE:CRY) will hold its 3Q20 earnings conference call with the financial community on 4th November 2020 at 4:30 PM Eastern Time.
The conference call will be webcast live on Internet at www.cryolife.com
Earnings Expectation
CryoLife, Inc. is expected to report third quarter earnings results, after market close, on Wednesday 4th November 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.04 per share from revenue of $ 59.24 million. Looking ahead, the full year loss are expected at $ 0.12 per share on the revenues of $ 249.57 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 292.00 million ~ $ 298.00 million, where as bottomline are predicted in a range of $ 0.15 ~ $ 0.17 per share
Click Here For More Historical Outlooks Of CryoLife, Inc.
CryoLife, Inc., together with its subsidiaries, manufactures, processes, and distributes medical devices and implantable human tissues for use in cardiac and vascular surgeries worldwide. The company operates in two segments, Medical Devices and Preservation Services. It offers BioGlue, an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X mechanical heart valves for aortic and mitral indications; cardiac preservation services; PhotoFix, a bovine pericardial patch for use in cardiac and vascular repairing activities; and PerClot, an absorbable powdered hemostat for use in surgical procedures, including cardiac, vascular, orthopedic, neurological, gynecological, ENT, and trauma surgeries.
